Just published! QR code attached! #ACR22 @RheumNow https://t.co/lMD0mFoT4M

“Rheumatic diseases - diseases of accelerated aging” With age: ⚖️ fat ⬆️ 💪🏻 muscle ⬇️ 👉 results in ⬇️fn ⬇️gait speed ⬇️grip 🌟what can we do? ⚡️start with basic diet and exercise advice ✅caloric restriction (⬇️350cal/day) ✅ resistance training #GeriRheum #ACR22 https://t.co/6KRrwCWBEZ

Botson et al. 52 week results MIRROR trial. MTX added to pegloticase. 71% vs 39% SU <6mg/dl. Infusion reaction 13% vs 32% if ab+ 0% vs 30% ab- @RheumNow #ACR22 Abstr#0001 #ACRbest https://t.co/1c3Va9NxNX https://t.co/dPGDyWue4G

• 12-month Findings of the Randomized, Double-Blind, Placebo-Controlled, Multicen…

England et al. Influence of FVC on choice of b/tsDMARD in RA-ILD. FVC predicts hospitalisation and mortality. However, it did not appear to influence choice of b/tsDMARD. Overall 67% of RA-ILD patients initiated TNFi, weird! @rheumnow #ACR22 Abstr#245 https://t.co/swuNHv96WD https://t.co/vy5FUPnNjo

• Influence of Forced Vital Capacity Impairment on Treatment Selection and Outcom…

Interesting observation: Late-onset PsA assoc'd w/ male sex, greater structural damage, higher frequency of arthritis, and greater loss of functionality (BASFI). Interestingly, shorter time of symptom duration to dx. Abs 0377 #ACR22 @RheumNow https://t.co/m15c37FltD https://t.co/3LRy4Ltde6

• Differences in Early-onset vs. Late-onset Psoriatic Arthritis: Data from the RE…

#ClinicalPearl #Methotrexate is recommended for Rx in all EXCEPT…#ACR22 @RheumNow

Difficult to treat #rheumatoidarthritis - phenotypes need to be defined and order of Rx may be v Impt. Well, it is really difficult @RheumNow #ACR22 session 12S127 https://t.co/x3bkUP590A

So does PsA affect your capacity to work? DISCOVER-2 analysis: It’s presenteeism, not absenteeism which is the issue PsA pts drag themselves into work, but treating them helps them actually do their job. We need to fund more rheumatologists! ABST0509 @RADoctor #ACR22 @RheumNow https://t.co/Jnac6mV9O5

#RheumPearl: Dr. J Stone shares useful #ophthalmology terms that #rheums should know. Note that IOI may not be idiopathic (do the workup- it might be #sarcoid myositis). Does @DGlaucomflecken have anything to add? #ACR22 @rheumnow https://t.co/bxWm7MlePj

Michailidou et al. Predictive models VTE in GCA. Predictors Age, inpatient status at the time of diagnosis of GCA, numberof admissions before diagnosis of GCA, Charlson comorbidity index @rheumnow #ACR22 Abstr#0458 https://t.co/TVZ53sERrS https://t.co/JzUuEZThY0

• Predictive Models for Thromboembolic Events in Giant Cell Arteritis: A US Veter…

BIOBADASAR study of cancer risk in RA patients with prev cancer treated with b/tsDMARD. No increased risk, but yet again abatacept numbers are making me slightly nervous! @rheumnow #ACR22 Abstr#0267 https://t.co/H8gYm9STT3 https://t.co/sEIS6Ljwao

• Cancer Risk with Biologic and Targeted Synthetic DMARDs in Patients with Rheuma…

Rheumatology Secrets & Pearl Lecture with Dr. John Stone: - Patient presenting with fever, headache, neck pain, and CPPD of multiple joints. - Consider Crowned Dens Syndrome. CT Neck showing calcification around Odontoid Process @RheumNow #ACR22 https://t.co/Md1bqzPyr5

Henningson et al. IV methylpred in GCA. No better visual acuity, higher cumulative GC at 3 months, higher diabetes. Interesting! I find it so hard not to give, in case the contralateral eye gets it, but no evidence for this @rheumnow #ACR22 Abstr#0459 https://t.co/yMcw2HGQUx https://t.co/tNKUgYNTdG

• The Use of Intravenous Methylprednisolone in Patients with Giant Cell Arteritis…

Morning stiffness has the highest correlate to disease activity in pregnant AS patients, as demonstrated in Abs 0374. I will indeed be focusing on this much more for my patients. #ACR22 #ACRbest @RheumNow https://t.co/9bmlQtGsLH https://t.co/qrxebQ6Ow1

• The BASDAI Index During Pregnancy - ACR Meeting Abstracts

RheumNow’s expanded coverage of the #ACR22 Annual meeting is sponsored in part by Novartis. All content chosen by RheumNow & its Faculty